These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 14966256)

  • 1. Pulmonary and hepatic toxicity due to nitrofurantoin and fluconazole treatment.
    Linnebur SA; Parnes BL
    Ann Pharmacother; 2004 Apr; 38(4):612-6. PubMed ID: 14966256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitrofurantoin-induced immune-mediated lung and liver disease.
    Schattner A; Von der Walde J; Kozak N; Sokolovskaya N; Knobler H
    Am J Med Sci; 1999 May; 317(5):336-40. PubMed ID: 10334121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pulmonary toxicity resulting from the use of nitrofurantoin].
    Broes MJ; Roelofs BF; Mudde AH; Hoornenborg E
    Ned Tijdschr Geneeskd; 2012; 156(44):A4990. PubMed ID: 23114172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid onset of iatrogenic adrenal insufficiency in a patient with cystic fibrosis-related liver disease treated with inhaled corticosteroids and a moderate CYP3A4 inhibitor.
    Hoover WC; Britton LJ; Gardner J; Jackson T; Gutierrez H
    Ann Pharmacother; 2011 Jul; 45(7-8):e38. PubMed ID: 21712512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How Common Are Pulmonary and Hepatic Adverse Effects in Older Adults Prescribed Nitrofurantoin?
    Claussen K; Stocks E; Bhat D; Fish J; Rubin CD
    J Am Geriatr Soc; 2017 Jun; 65(6):1316-1320. PubMed ID: 28306135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined nitrofurantoin toxicity to liver and lung.
    Reinhart HH; Reinhart E; Korlipara P; Peleman R
    Gastroenterology; 1992 Apr; 102(4 Pt 1):1396-9. PubMed ID: 1551546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary toxicity of nitrofurantoin.
    Witten CM
    Arch Phys Med Rehabil; 1989 Jan; 70(1):55-7. PubMed ID: 2644915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential fluconazole-induced carbamazepine toxicity.
    Nair DR; Morris HH
    Ann Pharmacother; 1999; 33(7-8):790-2. PubMed ID: 10466905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent acute nitrofurantoin-induced pulmonary toxicity.
    Williams EM; Triller DM
    Pharmacotherapy; 2006 May; 26(5):713-8. PubMed ID: 16718946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of the safety and efficacy of fluconazole in the treatment of onychomycosis.
    Smith SW; Sealy DP; Schneider E; Lackland D
    South Med J; 1995 Dec; 88(12):1217-20. PubMed ID: 7502113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitrofurantoin-induced pulmonary toxicity during pregnancy: a report of a case and review of the literature.
    Boggess KA; Benedetti TJ; Raghu G
    Obstet Gynecol Surv; 1996 Jun; 51(6):367-70. PubMed ID: 8771575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary lesions and autoimmune reactions after long-term nitrofurantoin treatment.
    Lundgren R; Bäck O; Wiman LG
    Scand J Respir Dis; 1975; 56(4):208-16. PubMed ID: 1198086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitrofurantoin-induced pulmonary toxicity: A case report and review of the literature.
    Kabbara WK; Kordahi MC
    J Infect Public Health; 2015; 8(4):309-13. PubMed ID: 25747822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival following fulminant hepatic failure from fluconazole induced hepatitis.
    Crerar-Gilbert A; Boots R; Fraenkel D; MacDonald GA
    Anaesth Intensive Care; 1999 Dec; 27(6):650-2. PubMed ID: 10631423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of fluconazole for the treatment of onychomycosis.
    Brown SJ
    Ann Pharmacother; 2009 Oct; 43(10):1684-91. PubMed ID: 19776299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute pulmonary toxicity to nitrofurantoin.
    Chudnofsky CR; Otten EJ
    J Emerg Med; 1989; 7(1):15-9. PubMed ID: 2703684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitrofurantoin-induced immune-mediated lung and liver disease.
    Milić R; Plavec G; Tufegdzić I; Tomić I; Sarac S; Loncarević O
    Vojnosanit Pregl; 2012 Jun; 69(6):536-40. PubMed ID: 22779302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subacute mitochondrial liver disease in a patient with AIDS: possible relationship to prolonged fluconazole administration.
    Guillaume MP; De Prez C; Cogan E
    Am J Gastroenterol; 1996 Jan; 91(1):165-8. PubMed ID: 8561126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Terbinafine-induced acute autoimmune hepatitis in the setting of hepatitis B virus infection.
    Paredes AH; Lewis JH
    Ann Pharmacother; 2007 May; 41(5):880-4. PubMed ID: 17426078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous resolution of nitrofurantoin-induced chronic pulmonary toxicity presenting with respiratory failure.
    Mir E; Malik JA; Lone SA; Mohi-Ud-Din R; Khalil M
    Adv Respir Med; 2017; 85(6):333-338. PubMed ID: 29288483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.